BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
13253 results:

  • 1. Video-Assisted vs Robotic-Assisted lung Lobectomies for Operating Room Resource Utilization and Patient Outcomes.
    Tupper HI; Lawson BL; Kipnis P; Patel AR; Ashiku SK; Roubinian NH; Myers LC; Liu VX; Velotta JB
    JAMA Netw Open; 2024 May; 7(5):e248881. PubMed ID: 38700865
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC.
    Lu Y; Langerman SS; McCain E; Magee K; Maund SL; Srivastava MK; Samant M
    JAMA Netw Open; 2024 May; 7(5):e249286. PubMed ID: 38700864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The cost-effectiveness of iruplinalkib versus alectinib in anaplastic lymphoma kinase-positive crizotinib-resistant advanced non-small-cell lung cancer patients in China.
    Dai Z; Xu J; Chang F; Zhou W; Ren T; Qiu J; Lu Y; Lu Y
    Front Public Health; 2024; 12():1333487. PubMed ID: 38699428
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting KRAS in pancreatic cancer.
    Stickler S; Rath B; Hamilton G
    Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
    Viana Veloso GG; Amaral FD; Nogueira-Rodrigues A
    BMC Cancer; 2024 Apr; 24(1):539. PubMed ID: 38679710
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases.
    Ostojic J; Kozic D; Panjkovic M; Georgievski-Brkic B; Dragicevic D; Lovrenski A; Boban J
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674308
    [No Abstract]    [Full Text] [Related]  

  • 9. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
    Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
    Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database.
    Sun R; Ning Z; Qin H; Zhang W; Teng Y; Jin C; Liu J; Wang A
    Sci Rep; 2024 Apr; 14(1):9552. PubMed ID: 38664423
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell lung cancer.
    Mooradian MJ; Cai L; Wang A; Qiao Y; Chander P; Whitaker RM
    JAMA Netw Open; 2024 Apr; 7(4):e247542. PubMed ID: 38648057
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
    Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
    Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]    [Full Text] [Related]  

  • 14. Development and validation of the hospice professional coping scale among Chinese nurses.
    Zhang Y; Zheng L; He Y; Han M; Wang Y; Xv J; Qiu H; Yang L
    BMC Health Serv Res; 2024 Apr; 24(1):491. PubMed ID: 38643136
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characteristics and outcomes of cancer patients admitted to intensive care units in cancer specialized hospitals in China.
    Liu W; Zhou D; Zhang L; Huang M; Quan R; Xia R; Ye Y; Zhang G; Shen Z;
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):205. PubMed ID: 38642154
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic Performance of MRI for the Detection of Pulmonary Nodules: A Systematic Review and Meta-Analysis.
    Cavion CC; Altmayer S; Forte GC; Feijó Andrade RG; Hochhegger DQDR; Zaguini Francisco M; Camargo C; Patel P; Hochhegger B
    Radiol Cardiothorac Imaging; 2024 Apr; 6(2):e230241. PubMed ID: 38634743
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
    Nishimura T; Fujimoto H; Fujiwara T; Ito K; Fujiwara A; Yuda H; Itani H; Naito M; Kodama S; Furuhashi K; Yagi A; Saiki H; Yasuma T; Okano T; Tomaru A; Tanigawa M; Yoshida M; Hataji O; Ibata H; D'Alessandro-Gabazza CN; Gabazza EC; Kobayashi T
    Cancer Med; 2024 Apr; 13(8):e7188. PubMed ID: 38629295
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A pH-responsive nanoplatform with dual-modality imaging for enhanced cancer phototherapy and diagnosis of lung metastasis.
    Yuan M; Han Z; Li Y; Zhan X; Sun Y; He B; Liang Y; Luo K; Li F
    J Nanobiotechnology; 2024 Apr; 22(1):180. PubMed ID: 38622591
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effectiveness of an ERAS-based exercise-nutrition management model in enhancing postoperative recovery for thoracoscopic radical resection of lung cancer: A randomized controlled trial.
    Huang L; Hu Y; Chen J
    Medicine (Baltimore); 2024 Apr; 103(15):e37667. PubMed ID: 38608111
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting.
    Kumbrink J; Demes MC; Jeroch J; Bräuninger A; Hartung K; Gerstenmaier U; Marienfeld R; Hillmer A; Bohn N; Lehning C; Ferch F; Wild P; Gattenlöhner S; Möller P; Klauschen F; Jung A
    Pathol Oncol Res; 2024; 30():1611590. PubMed ID: 38605929
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 663.